Since 68Ga-labeled radiotracers for somatostatin-receptor (SSTR) and prostate-specific membrane antigen (PSMA) imaging for neuroendocrine tumors and prostate cancer are frequently used in the clinic, the availability of such generators has improved 29. The gene discussed is FOLH1; the disease is neuroendocrine neoplasm.